{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190610",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "58998",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s000lbl.pdf",
              "date": "20190610",
              "type": "Label"
            },
            {
              "id": "59226",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761121Orig1s000TOC.html",
              "date": "20190702",
              "type": "Review"
            },
            {
              "id": "59227",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761121Orig1s000ltr.pdf",
              "date": "20190703",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20200918",
          "review_priority": "N/A",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "65896",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761121Orig1s003ltr.pdf",
              "date": "20210112",
              "type": "Letter"
            },
            {
              "id": "65898",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121Orig1s003lbl.pdf",
              "date": "20210112",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20230419",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "74031",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761121s008lbl.pdf",
              "date": "20230420",
              "type": "Label"
            },
            {
              "id": "74033",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761121Orig1s008ltr.pdf",
              "date": "20230420",
              "type": "Letter"
            },
            {
              "id": "77697",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/761121Orig1s008TOC.html",
              "date": "20240304",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20260318",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "85430",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761121Orig1s017ltr.pdf",
              "date": "20260320",
              "type": "Letter"
            },
            {
              "id": "85483",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761121s017lbl.pdf",
              "date": "20260324",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761121",
      "sponsor_name": "GENENTECH",
      "openfda": {
        "application_number": [
          "BLA761121"
        ],
        "brand_name": [
          "POLIVY"
        ],
        "generic_name": [
          "POLATUZUMAB VEDOTIN"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-103",
          "50242-105"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "POLATUZUMAB VEDOTIN"
        ],
        "rxcui": [
          "2174095",
          "2174100",
          "2398131",
          "2398133"
        ],
        "spl_id": [
          "6e6d980b-007b-4e04-b908-dd456f137d15"
        ],
        "spl_set_id": [
          "20a16ab2-f338-4abb-9dcd-254bd949a2bc"
        ],
        "package_ndc": [
          "50242-105-01",
          "50242-103-01"
        ],
        "unii": [
          "KG6VO684Z6"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "POLIVY",
          "active_ingredients": [
            {
              "name": "POLATUZUMAB VEDOTIN-PIIQ",
              "strength": "140MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "POLIVY",
          "active_ingredients": [
            {
              "name": "POLATUZUMAB VEDOTIN-PIIQ",
              "strength": "30MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}